Stay updated on Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page.

Latest updates to the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected403 Forbidden error is shown on the study page, replacing the normal study record content and navigation. Users cannot access the CAPItello-291 trial details as a result.SummaryDifference16%

- Check17 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new published revision of the page. This reflects a general update to the page's metadata or UI rather than substantive changes to the study details.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous (v3.6.5), indicating a small update to the page just in its metadata or formatting. This change does not modify the substantive study details or participation criteria.SummaryDifference0.0%

- Check38 days agoChange DetectedNIH grant/contract notes for 2019 and 2023 were added to the study's funding information. This updates the attribution of U.S. NIH support for CAPItello-291.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor platform update. There is no visible change to the study details on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedFooter now shows Revision: v3.6.4, indicating a site version update from the previous v3.6.3.SummaryDifference0.0%

Stay in the know with updates to Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page.